1 Hepatitis B Vaccination Market Overview 1.1 Product Overview and Scope of Hepatitis B Vaccination 1.2 Hepatitis B Vaccination Segment by Type 1.2.1 Global Hepatitis B Vaccination Market Value Comparison by Type (2023-2029) 1.2.2 Yeast Derived 1.2.3 CHO Derived 1.3 Hepatitis B Vaccination Segment by Application 1.3.1 Global Hepatitis B Vaccination Market Value by Application: (2023-2029) 1.3.2 Children 1.3.3 Adult 1.4 Global Hepatitis B Vaccination Market Size Estimates and Forecasts 1.4.1 Global Hepatitis B Vaccination Revenue 2018-2029 1.4.2 Global Hepatitis B Vaccination Sales 2018-2029 1.4.3 Global Hepatitis B Vaccination Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Hepatitis B Vaccination Market Competition by Manufacturers 2.1 Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2018-2023) 2.2 Global Hepatitis B Vaccination Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Hepatitis B Vaccination Average Price by Manufacturers (2018-2023) 2.4 Global Hepatitis B Vaccination Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Hepatitis B Vaccination, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Hepatitis B Vaccination, Product Type & Application 2.7 Hepatitis B Vaccination Market Competitive Situation and Trends 2.7.1 Hepatitis B Vaccination Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Hepatitis B Vaccination Players Market Share by Revenue 2.7.3 Global Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Hepatitis B Vaccination Retrospective Market Scenario by Region 3.1 Global Hepatitis B Vaccination Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Hepatitis B Vaccination Global Hepatitis B Vaccination Sales by Region: 2018-2029 3.2.1 Global Hepatitis B Vaccination Sales by Region: 2018-2023 3.2.2 Global Hepatitis B Vaccination Sales by Region: 2024-2029 3.3 Global Hepatitis B Vaccination Global Hepatitis B Vaccination Revenue by Region: 2018-2029 3.3.1 Global Hepatitis B Vaccination Revenue by Region: 2018-2023 3.3.2 Global Hepatitis B Vaccination Revenue by Region: 2024-2029 3.4 North America Hepatitis B Vaccination Market Facts & Figures by Country 3.4.1 North America Hepatitis B Vaccination Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Hepatitis B Vaccination Sales by Country (2018-2029) 3.4.3 North America Hepatitis B Vaccination Revenue by Country (2018-2029) 3.4.4 United States 3.4.5 Canada 3.5 Europe Hepatitis B Vaccination Market Facts & Figures by Country 3.5.1 Europe Hepatitis B Vaccination Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Hepatitis B Vaccination Sales by Country (2018-2029) 3.5.3 Europe Hepatitis B Vaccination Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Hepatitis B Vaccination Market Facts & Figures by Country 3.6.1 Asia Pacific Hepatitis B Vaccination Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Hepatitis B Vaccination Sales by Country (2018-2029) 3.6.3 Asia Pacific Hepatitis B Vaccination Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 China Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.7 Latin America Hepatitis B Vaccination Market Facts & Figures by Country 3.7.1 Latin America Hepatitis B Vaccination Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Hepatitis B Vaccination Sales by Country (2018-2029) 3.7.3 Latin America Hepatitis B Vaccination Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Hepatitis B Vaccination Market Facts & Figures by Country 3.8.1 Middle East and Africa Hepatitis B Vaccination Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Hepatitis B Vaccination Sales by Country (2018-2029) 3.8.3 Middle East and Africa Hepatitis B Vaccination Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Hepatitis B Vaccination Sales by Type (2018-2029) 4.1.1 Global Hepatitis B Vaccination Sales by Type (2018-2023) 4.1.2 Global Hepatitis B Vaccination Sales by Type (2024-2029) 4.1.3 Global Hepatitis B Vaccination Sales Market Share by Type (2018-2029) 4.2 Global Hepatitis B Vaccination Revenue by Type (2018-2029) 4.2.1 Global Hepatitis B Vaccination Revenue by Type (2018-2023) 4.2.2 Global Hepatitis B Vaccination Revenue by Type (2024-2029) 4.2.3 Global Hepatitis B Vaccination Revenue Market Share by Type (2018-2029) 4.3 Global Hepatitis B Vaccination Price by Type (2018-2029) 5 Segment by Application 5.1 Global Hepatitis B Vaccination Sales by Application (2018-2029) 5.1.1 Global Hepatitis B Vaccination Sales by Application (2018-2023) 5.1.2 Global Hepatitis B Vaccination Sales by Application (2024-2029) 5.1.3 Global Hepatitis B Vaccination Sales Market Share by Application (2018-2029) 5.2 Global Hepatitis B Vaccination Revenue by Application (2018-2029) 5.2.1 Global Hepatitis B Vaccination Revenue by Application (2018-2023) 5.2.2 Global Hepatitis B Vaccination Revenue by Application (2024-2029) 5.2.3 Global Hepatitis B Vaccination Revenue Market Share by Application (2018-2029) 5.3 Global Hepatitis B Vaccination Price by Application (2018-2029) 6 Key Companies Profiled 6.1 GSK 6.1.1 GSK Corporation Information 6.1.2 GSK Description and Business Overview 6.1.3 GSK Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.1.4 GSK Hepatitis B Vaccination Product Portfolio 6.1.5 GSK Recent Developments/Updates 6.2 NCPC 6.2.1 NCPC Corporation Information 6.2.2 NCPC Description and Business Overview 6.2.3 NCPC Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.2.4 NCPC Hepatitis B Vaccination Product Portfolio 6.2.5 NCPC Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Merck Hepatitis B Vaccination Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Bio Kangtai 6.4.1 Bio Kangtai Corporation Information 6.4.2 Bio Kangtai Description and Business Overview 6.4.3 Bio Kangtai Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Bio Kangtai Hepatitis B Vaccination Product Portfolio 6.4.5 Bio Kangtai Recent Developments/Updates 6.5 Dynavax 6.5.1 Dynavax Corporation Information 6.5.2 Dynavax Description and Business Overview 6.5.3 Dynavax Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.5.4 Dynavax Hepatitis B Vaccination Product Portfolio 6.5.5 Dynavax Recent Developments/Updates 6.6 Hissen 6.6.1 Hissen Corporation Information 6.6.2 Hissen Description and Business Overview 6.6.3 Hissen Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Hissen Hepatitis B Vaccination Product Portfolio 6.6.5 Hissen Recent Developments/Updates 6.7 KM Biologics 6.6.1 KM Biologics Corporation Information 6.6.2 KM Biologics Description and Business Overview 6.6.3 KM Biologics Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.4.4 KM Biologics Hepatitis B Vaccination Product Portfolio 6.7.5 KM Biologics Recent Developments/Updates 6.8 LG Life Sciences 6.8.1 LG Life Sciences Corporation Information 6.8.2 LG Life Sciences Description and Business Overview 6.8.3 LG Life Sciences Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.8.4 LG Life Sciences Hepatitis B Vaccination Product Portfolio 6.8.5 LG Life Sciences Recent Developments/Updates 6.9 Serum Institute 6.9.1 Serum Institute Corporation Information 6.9.2 Serum Institute Description and Business Overview 6.9.3 Serum Institute Hepatitis B Vaccination Sales, Revenue and Gross Margin (2018-2023) 6.9.4 Serum Institute Hepatitis B Vaccination Product Portfolio 6.9.5 Serum Institute Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Hepatitis B Vaccination Industry Chain Analysis 7.2 Hepatitis B Vaccination Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Hepatitis B Vaccination Production Mode & Process 7.4 Hepatitis B Vaccination Sales and Marketing 7.4.1 Hepatitis B Vaccination Sales Channels 7.4.2 Hepatitis B Vaccination Distributors 7.5 Hepatitis B Vaccination Customers 8 Hepatitis B Vaccination Market Dynamics 8.1 Hepatitis B Vaccination Industry Trends 8.2 Hepatitis B Vaccination Market Drivers 8.3 Hepatitis B Vaccination Market Challenges 8.4 Hepatitis B Vaccination Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Hepatitis B Vaccination Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Hepatitis B Vaccination Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Hepatitis B Vaccination Market Competitive Situation by Manufacturers in 2022 Table 4. Global Hepatitis B Vaccination Sales (Units) of Key Manufacturers (2018-2023) Table 5. Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2018-2023) Table 6. Global Hepatitis B Vaccination Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Hepatitis B Vaccination Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Hepatitis B Vaccination Average Price (US$/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Hepatitis B Vaccination, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Hepatitis B Vaccination, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Hepatitis B Vaccination, Product Type & Application Table 12. Global Key Manufacturers of Hepatitis B Vaccination, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Hepatitis B Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccination as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Hepatitis B Vaccination Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Hepatitis B Vaccination Sales by Region (2018-2023) & (Units) Table 18. Global Hepatitis B Vaccination Sales Market Share by Region (2018-2023) Table 19. Global Hepatitis B Vaccination Sales by Region (2024-2029) & (Units) Table 20. Global Hepatitis B Vaccination Sales Market Share by Region (2024-2029) Table 21. Global Hepatitis B Vaccination Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Hepatitis B Vaccination Revenue Market Share by Region (2018-2023) Table 23. Global Hepatitis B Vaccination Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Hepatitis B Vaccination Revenue Market Share by Region (2024-2029) Table 25. North America Hepatitis B Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Hepatitis B Vaccination Sales by Country (2018-2023) & (Units) Table 27. North America Hepatitis B Vaccination Sales by Country (2024-2029) & (Units) Table 28. North America Hepatitis B Vaccination Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Hepatitis B Vaccination Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Hepatitis B Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Hepatitis B Vaccination Sales by Country (2018-2023) & (Units) Table 32. Europe Hepatitis B Vaccination Sales by Country (2024-2029) & (Units) Table 33. Europe Hepatitis B Vaccination Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Hepatitis B Vaccination Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Hepatitis B Vaccination Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Hepatitis B Vaccination Sales by Region (2018-2023) & (Units) Table 37. Asia Pacific Hepatitis B Vaccination Sales by Region (2024-2029) & (Units) Table 38. Asia Pacific Hepatitis B Vaccination Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Hepatitis B Vaccination Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Hepatitis B Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Hepatitis B Vaccination Sales by Country (2018-2023) & (Units) Table 42. Latin America Hepatitis B Vaccination Sales by Country (2024-2029) & (Units) Table 43. Latin America Hepatitis B Vaccination Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Hepatitis B Vaccination Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Hepatitis B Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Hepatitis B Vaccination Sales by Country (2018-2023) & (Units) Table 47. Middle East & Africa Hepatitis B Vaccination Sales by Country (2024-2029) & (Units) Table 48. Middle East & Africa Hepatitis B Vaccination Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Hepatitis B Vaccination Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Hepatitis B Vaccination Sales (Units) by Type (2018-2023) Table 51. Global Hepatitis B Vaccination Sales (Units) by Type (2024-2029) Table 52. Global Hepatitis B Vaccination Sales Market Share by Type (2018-2023) Table 53. Global Hepatitis B Vaccination Sales Market Share by Type (2024-2029) Table 54. Global Hepatitis B Vaccination Revenue (US$ Million) by Type (2018-2023) Table 55. Global Hepatitis B Vaccination Revenue (US$ Million) by Type (2024-2029) Table 56. Global Hepatitis B Vaccination Revenue Market Share by Type (2018-2023) Table 57. Global Hepatitis B Vaccination Revenue Market Share by Type (2024-2029) Table 58. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2018-2023) Table 59. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2024-2029) Table 60. Global Hepatitis B Vaccination Sales (Units) by Application (2018-2023) Table 61. Global Hepatitis B Vaccination Sales (Units) by Application (2024-2029) Table 62. Global Hepatitis B Vaccination Sales Market Share by Application (2018-2023) Table 63. Global Hepatitis B Vaccination Sales Market Share by Application (2024-2029) Table 64. Global Hepatitis B Vaccination Revenue (US$ Million) by Application (2018-2023) Table 65. Global Hepatitis B Vaccination Revenue (US$ Million) by Application (2024-2029) Table 66. Global Hepatitis B Vaccination Revenue Market Share by Application (2018-2023) Table 67. Global Hepatitis B Vaccination Revenue Market Share by Application (2024-2029) Table 68. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2018-2023) Table 69. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2024-2029) Table 70. GSK Corporation Information Table 71. GSK Description and Business Overview Table 72. GSK Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 73. GSK Hepatitis B Vaccination Product Table 74. GSK Recent Developments/Updates Table 75. NCPC Corporation Information Table 76. NCPC Description and Business Overview Table 77. NCPC Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 78. NCPC Hepatitis B Vaccination Product Table 79. NCPC Recent Developments/Updates Table 80. Merck Corporation Information Table 81. Merck Description and Business Overview Table 82. Merck Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Merck Hepatitis B Vaccination Product Table 84. Merck Recent Developments/Updates Table 85. Bio Kangtai Corporation Information Table 86. Bio Kangtai Description and Business Overview Table 87. Bio Kangtai Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. Bio Kangtai Hepatitis B Vaccination Product Table 89. Bio Kangtai Recent Developments/Updates Table 90. Dynavax Corporation Information Table 91. Dynavax Description and Business Overview Table 92. Dynavax Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. Dynavax Hepatitis B Vaccination Product Table 94. Dynavax Recent Developments/Updates Table 95. Hissen Corporation Information Table 96. Hissen Description and Business Overview Table 97. Hissen Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Hissen Hepatitis B Vaccination Product Table 99. Hissen Recent Developments/Updates Table 100. KM Biologics Corporation Information Table 101. KM Biologics Description and Business Overview Table 102. KM Biologics Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. KM Biologics Hepatitis B Vaccination Product Table 104. KM Biologics Recent Developments/Updates Table 105. LG Life Sciences Corporation Information Table 106. LG Life Sciences Description and Business Overview Table 107. LG Life Sciences Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. LG Life Sciences Hepatitis B Vaccination Product Table 109. LG Life Sciences Recent Developments/Updates Table 110. Serum Institute Corporation Information Table 111. Serum Institute Description and Business Overview Table 112. Serum Institute Hepatitis B Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Serum Institute Hepatitis B Vaccination Product Table 114. Serum Institute Recent Developments/Updates Table 115. Key Raw Materials Lists Table 116. Raw Materials Key Suppliers Lists Table 117. Hepatitis B Vaccination Distributors List Table 118. Hepatitis B Vaccination Customers List Table 119. Hepatitis B Vaccination Market Trends Table 120. Hepatitis B Vaccination Market Drivers Table 121. Hepatitis B Vaccination Market Challenges Table 122. Hepatitis B Vaccination Market Restraints Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Hepatitis B Vaccination Figure 2. Global Hepatitis B Vaccination Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Hepatitis B Vaccination Market Share by Type in 2022 & 2029 Figure 4. Yeast Derived Product Picture Figure 5. CHO Derived Product Picture Figure 6. Global Hepatitis B Vaccination Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Hepatitis B Vaccination Market Share by Application in 2022 & 2029 Figure 8. Children Figure 9. Adult Figure 10. Global Hepatitis B Vaccination Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 11. Global Hepatitis B Vaccination Market Size (2018-2029) & (US$ Million) Figure 12. Global Hepatitis B Vaccination Sales (2018-2029) & (Units) Figure 13. Global Hepatitis B Vaccination Average Price (US$/Unit) & (2018-2029) Figure 14. Hepatitis B Vaccination Report Years Considered Figure 15. Hepatitis B Vaccination Sales Share by Manufacturers in 2022 Figure 16. Global Hepatitis B Vaccination Revenue Share by Manufacturers in 2022 Figure 17. The Global 5 and 10 Largest Hepatitis B Vaccination Players: Market Share by Revenue in 2022 Figure 18. Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 19. Global Hepatitis B Vaccination Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 20. North America Hepatitis B Vaccination Sales Market Share by Country (2018-2029) Figure 21. North America Hepatitis B Vaccination Revenue Market Share by Country (2018-2029) Figure 22. United States Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 23. Canada Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 24. Europe Hepatitis B Vaccination Sales Market Share by Country (2018-2029) Figure 25. Europe Hepatitis B Vaccination Revenue Market Share by Country (2018-2029) Figure 26. Germany Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 27. France Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. U.K. Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. Italy Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. Russia Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Asia Pacific Hepatitis B Vaccination Sales Market Share by Region (2018-2029) Figure 32. Asia Pacific Hepatitis B Vaccination Revenue Market Share by Region (2018-2029) Figure 33. China Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 34. Japan Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. South Korea Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. India Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. Australia Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. China Taiwan Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Indonesia Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Thailand Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Malaysia Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Latin America Hepatitis B Vaccination Sales Market Share by Country (2018-2029) Figure 43. Latin America Hepatitis B Vaccination Revenue Market Share by Country (2018-2029) Figure 44. Mexico Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 45. Brazil Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 46. Argentina Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Middle East & Africa Hepatitis B Vaccination Sales Market Share by Country (2018-2029) Figure 48. Middle East & Africa Hepatitis B Vaccination Revenue Market Share by Country (2018-2029) Figure 49. Turkey Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 50. Saudi Arabia Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 51. UAE Hepatitis B Vaccination Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Global Sales Market Share of Hepatitis B Vaccination by Type (2018-2029) Figure 53. Global Revenue Market Share of Hepatitis B Vaccination by Type (2018-2029) Figure 54. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2018-2029) Figure 55. Global Sales Market Share of Hepatitis B Vaccination by Application (2018-2029) Figure 56. Global Revenue Market Share of Hepatitis B Vaccination by Application (2018-2029) Figure 57. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2018-2029) Figure 58. Hepatitis B Vaccination Value Chain Figure 59. Hepatitis B Vaccination Production Process Figure 60. Channels of Distribution (Direct Vs Distribution) Figure 61. Distributors Profiles Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

GSK NCPC Merck Bio Kangtai Dynavax Hissen KM Biologics LG Life Sciences Serum Institute